The SOS (Stenting Of Saphenous Vein Grafts) Trial

Completed · Phase 3

Conditions studied: Coronary Artery Bypass, Arteriosclerosis

In brief

The main purpose of this study is to determine whether implantation of a paclitaxel-eluting stent (Taxus™) in saphenous vein graft lesions will reduce the incidence of in-stent restenosis after 12 months when compared to a similar bare metal stent.

Key facts

Study ID
NCT00247208
Run by
North Texas Veterans Healthcare System
People needed
80
Starts
2005-05-01
Expected to finish
2011-06-01
Last updated by the study team
2012-04-26

Who can join

Age: 18 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

You may not qualify if…

Where it is running

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.